Over 4.7m people in SA placed on new HIV med in four years

In what is likely one of the largest treatment rollouts in South African history, well over four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction around four years ago. Now, according to a recent study published in the Lancet medical journal, use of dolutegravir in South Africa is associated with more people staying on treatment and higher rates of viral suppression. Elri Voigt unpacks the study findings and assesses progress in the country’s switch to dolutegravir-based HIV treatment.

Read More

HIV vaccine research set to change focus in wake of Mosaico disappointment

Top South African HIV clinicians are setting their sights on different approaches to finding an HIV vaccine after the “disappointing” news that the Mosaico trial was stopped early because the vaccine did not show any efficacy. The search for an HIV jab now seems set to pivot from vaccines that induce T-cell immunity to ones that induce B-cell immunity. Adele Baleta unpacks what that means and the reasoning behind it.

Read More

OPINION: How can we make surgical care accessible by drawing on lessons from the AIDS movement?

The quest for access to equitable and quality surgical care for all will not be won only in board rooms, theatres, or hospital corridors. We have to take this quest into communities and build alliances. In that respect, we can learn from one of the best examples of how community participation and mobilisation can help change health policy – the movement to ensure access to affordable and universal anti-retroviral treatment for persons living with HIV, argues Professor Kathryn Chu and Sangeun Lee.

Read More

OPINION: Mid-term budget fails to show the way to a more resilient recovery

The Medium-term Budget Policy Statement (MTBPS) was tabled amid a grim global economic outlook and a climate of increasing political uncertainty, electricity supply challenges, and very high unemployment. Russell Rensburg argues the MTBPS fails to provide a credible path toward a resilient recovery and sets out what can be done to strengthen governance and build social solidarity around the recovery we need.

Read More

Human resource issues at root of Free State health problems, report suggests

Shortages of healthcare workers are contributing to long waiting times at healthcare facilities, poor treatment adherence, and are undermining the response to HIV and tuberculosis (TB) in the Free State, findings in a new report show. Refilwe Mochoari attended the launch of the report and asked the Free State Department of Health for its response.

Read More

In-depth: Getting Gauteng’s HIV and TB response back on track

From March to July this year, the Gauteng Department of Health recorded 57 848 TB tests – a decrease of about 30 000 tests compared to the same period last year. The province performed better with HIV testing, although the HIV response has faltered in other areas. Melissa Javan makes sense of the province’s numbers and speaks to activists and community health workers about the impact of lockdown on their services and plans to get things back on track.  

Read More

‘Welcome Back Service’ aims to help people get back on HIV treatment

While South Africa is doing well on some of the UNAIDS HIV targets for 2020, one target we are set to miss is ensuring that 90% of people diagnosed with HIV are on antiretroviral therapy. Partly in response to this problem, the ‘Welcome back’ campaign started by Doctors without Borders aims to make it easier for people who have stopped taking treatment to restart. Tiyese Jeranji reports.

Read More

Opinion: When civil society can’t do its work, adherence to HIV treatment dips.

If South Africa is forced to go into a COVID-19 lockdown again, HIV support groups and adherence clubs should remain functional to make sure that everyone is supported, has regular access to information and treatment, and that people are motivated to adhere to treatment, argue Annah Maluleke and Solanga Milambo.

Read More

New medicines should make life easier for kids living with HIV

HIV medicines for children often taste bitter, pills are large, and for many children there is a lot of medication to take. This makes it hard to take treatment as prescribed. Tiyese Jeranji looks at the challenges with currently available HIV medicines for children, what innovations are in the pipeline, and how HIV treatment is being tailored to suit the needs of children.

Read More